Mandate

Vinge advises IBT on share issues

November 24, 2017

Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection with a combined directed issue and rights offering of approximately SEK 545 million.

The Vinge team includes Erik Sjöman, Christian Lindhé, Kristoffer Franzkeit, Ludvig Frithiof and Astrid Karlsson.

Related

Vinge has advised Sertion AB in connection with the acquisition of Svensk Anläggning och Driftteknik AB

Through the acquisition, Sertion takes a further step in its development as a leading international infrastructure and installation group within complex HVAC systems, technical infrastructure, and industrial piping. Svensk Anläggning och Driftteknik AB specializes in certified welding and installation of industrial piping.
February 10, 2026

Vinge advises Mirova in connection with the acquisition of the Boarp, Dållebo and Fågelås wind farms

Vinge has advised Mirova, a subsidiary of Natixis Investment Managers focusing on sustainable investments, in connection with the acquisition of the three Swedish onshore wind farms Boarp, Dållebo and Fågelås.
February 10, 2026

Vinge has advised Viva Wine Group AB in connection with the acquisition of the Norwegian beverage company Alpha Brands

Vinge has advised Viva Wine Group AB in connection with the acquisition of 60 percent of the shares in the Norwegian beverage company Alpha Brands, for an initial cash purchase price of MNOK 33, with a possible earn-out based on the company's performance development.
February 09, 2026